Market Research Logo

Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review

Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review provides

- you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing; microarray services; and instrument services, training and consulting. Illumina caters its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations. The company sells its products through direct sales and distributors in the Americas, Asia-Pacific, Europe, the Middle East and Africa. Illumina is headquartered in San Diego, California, the US.

Illumina Inc Key Recent Developments

Apr 24,2018: Illumina Reports Financial Results for First Quarter of Fiscal Year 2018
Mar 12,2018: Illumina Names Dr. Phil Febbo Chief Medical Officer
Feb 12,2018: New GUINNESS WORLD RECORDS Title Set for Fastest Genetic Diagnosis
Jan 30,2018: Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017
Jan 08,2018: Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Illumina Inc - Key Facts
Illumina Inc - Key Employees
Illumina Inc - Key Employee Biographies
Illumina Inc - Major Products and Services
Illumina Inc - History
Illumina Inc - Company Statement
Illumina Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Illumina Inc - Business Description
Product Category: Consumables
Overview
Performance
Product Category: Instruments
Overview
Performance
Product Category: Services and Others
Overview
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other Markets
Performance
Geographical Segment: The US
Performance
R&D Overview
Illumina Inc - SWOT Analysis
SWOT Analysis - Overview
Illumina Inc - Strengths
Illumina Inc - Weaknesses
Illumina Inc - Opportunities
Illumina Inc - Threats
Illumina Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Illumina Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Illumina Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
Illumina Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 24, 2018: Illumina Reports Financial Results for First Quarter of Fiscal Year 2018
Mar 12, 2018: Illumina Names Dr. Phil Febbo Chief Medical Officer
Feb 12, 2018: New GUINNESS WORLD RECORDS Title Set for Fastest Genetic Diagnosis
Jan 30, 2018: Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017
Jan 08, 2018: Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology
Dec 11, 2017: Illumina Names Aimee Hoyt Chief People Officer, Bringing 20+ Years of Senior Human Resources Leadership from Global Technology Companies
Nov 08, 2017: Illumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding Decades of Leadership Experience in Healthcare
Oct 24, 2017: Illumina Reports Financial Results for Third Quarter of Fiscal Year 2017
Oct 17, 2017: Dr. David Walt of Wyss Institute to Speak at Powering Precision Health 2017
Aug 01, 2017: llumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Illumina Inc, Key Facts
Illumina Inc, Key Employees
Illumina Inc, Key Employee Biographies
Illumina Inc, Major Products and Services
Illumina Inc, History
Illumina Inc, Other Locations
Illumina Inc, Subsidiaries
Illumina Inc, Joint Venture
Illumina Inc, Key Competitors
Illumina Inc, Ratios based on current share price
Illumina Inc, Annual Ratios
Illumina Inc, Annual Ratios (Cont...1)
Illumina Inc, Annual Ratios (Cont...2)
Illumina Inc, Interim Ratios
Illumina Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Illumina Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
Illumina Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Illumina Inc, Performance Chart (2013 - 2017)
Illumina Inc, Ratio Charts
Illumina Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Illumina Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report